CD8A and COVID-19: Patients with COVID-19 and convalescent patients show that a T cell response is associated with a reduction in disease severity, suggesting that a specific T cell response (CD4 and CD8) against SARS-CoV-2 could be important for the control and resolution of the primary infection [77].